Articles & Insights
The Two-Minute Rule
June 24, 2026

A single IVF cycle in the United States averages around $23,000, with most patients landing somewhere in the $15,000 to $30,000 range depending on geography, clinic, and protocol (source).
That number is rarely the full picture. The base IVF fee covers the core procedure: monitoring, retrieval, embryology, anesthesia, and one transfer. Almost everything else is billed separately:
Most patients understand, in the abstract, that fertility care is expensive. Few understand how many separate billing events one cycle actually generates, or how those events stack across the two or three cycles most patients will ultimately need (source).
Why Patients Get Surprised Anyway
Even patients who do their homework get blindsided. In the broader healthcare market, 87% of consumers said they were surprised by a medical bill in a recent year (source), and 64% report they didn't receive a cost estimate before care (source). Fertility patients are even more exposed.
The reasons stack on top of each other. A single cycle often generates bills from three or four separate entities: the group itself, an outside genetics lab, a specialty pharmacy, and sometimes an independent anesthesia group. Estimates given at the financial counseling visit don't always account for protocol changes, additional retrievals, or freeze-all decisions made mid-cycle. Insurance coverage, when it exists, is fragmented across diagnostic codes, lifetime caps, and prior-authorization windows. Patients with employer fertility benefits often discover that their carve-out pays a portion and the group bills the rest, with no single statement showing the total.
The patient ends up doing the integration work the billing system should be doing. She receives a statement from the group, a separate statement from the genetics lab, an EOB from her insurance, an explanation from her benefit administrator, and a charge from the specialty pharmacy. None of those documents agree on what she owes, and none of them reference the others. Her job, on top of going through fertility treatment, is to reconcile them.
The pattern is consistent. The more entities involved in delivering care, the more likely the patient will be confused by what they owe and to whom. The group that owns the patient relationship is, by default, the one she calls when something doesn't add up. That call goes to a billing team that often doesn't have visibility into the third-party charges either.
Transparency Is a Competitive Differentiator, Not a Courtesy
Only 21% of healthcare providers consider price transparency a top priority for patients (source). In a field where patients are spending five-figure sums out of pocket and choosing among multiple clinics, that is a competitive opening.
Groups that lead with transparency tend to share a few characteristics. They deliver detailed good faith estimates before treatment begins, not at the moment of payment. They consolidate everything billed under their own roof into a single statement, with clear separation between group charges and pass-through charges from third-party labs or pharmacies. They give patients real-time visibility into balances, payment plan progress, and what is coming next. When something changes mid-cycle, they tell the patient the same day, not three weeks later when the bill arrives.
The conversation patients want isn't reactive, either. 62% of consumers say they want to discuss payment plan or financing options before the procedure, not after the bill arrives (source). For fertility patients facing $15,000 to $30,000 per cycle and a likely two or three cycles ahead of them, the question isn't "can you bill me?" It is "can I afford this at all?" Groups that surface that conversation in the consult, not after the balance lands, win the patient at the moment of decision.
When patients can see the full picture, three things change. They make care decisions based on medical need rather than financial fear. They pay faster. They refer.
What Modern Fertility Billing Actually Looks Like
The infrastructure to deliver this kind of clarity already exists, and it does not require asking patients to download an app or remember another login. Mobile-first statements meet patients where they already are, and the performance difference between digital and paper is dramatic. Roughly 44% of electronic statements result in immediate payment, compared to about 2% for paper statements (source).
That gap is operational, not theoretical. A group that sends paper statements is functionally writing off most of its same-day collection potential. The patient who would have paid in two minutes if she had received a text instead receives a paper statement that sits on a counter for three weeks. By the time it is opened, the next bill may have already arrived. The financial counseling conversation that happened at the start of treatment has long since faded from memory, and the patient is now reading a statement out of context.
Where PatientPay Fits
PatientPay was built around this gap and works with some of the largest fertility providers. The platform delivers branded, mobile-first statements directly to the patient with no app, no login, and no portal. It supports payment plans and autopay so financial counseling can extend cleanly into the entire treatment journey. It gives the group a single source of truth for what each patient owes, even when that picture spans multiple cycles, multiple guarantors, and a coordinated benefit.
Fertility patients are demanding clarity, and the groups delivering it are pulling ahead in a market where trust is the differentiator that travels.